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Mantle cell lymphoma (MCL) of the colon is a rare entity, 
usually presenting as lymphomatous polyposis. We re-
port the case of a 43-year-old male with an unusual co-
lonic MCL in the form of a single exophytic and ulcerous 
lesion with necrotic areas associated with an ileo-cecal 
intussusception. The endoscopic appearance suggested 
adenocarcinoma. However, the diagnosis was made by 
histology and immunohistochemistry studies of the en-
doscopic biopsies. 
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INTRODUCTION
Mantle cell lymphoma (MCL) is a rare and aggressive B-cell 
non-Hodgkin lymphoma (NHL) defined by the translocation 
t (11; 14) (q13; q32) that results in the overexpression of 
protein cyclin D1 (1). It comprises 2-10% of all NHLs and 
frequently involves extranodal sites, including the spleen, 
bone marrow and gastrointestinal tract. Gastrointestinal 
involvement is found in 5-20% of all cases of MCL (2). 
Primary gastrointestinal lymphoma is very rare, accounting 
for only about 1-4% of all gastrointestinal malignancies (3). 
MCL has one of the worst prognoses of all B-cell NHLs, 
with a 5-year survival as low as 27% (4). Primary MCL of 
the colon is a rare entity, with only a few case reports in the 
literature and the most common endoscopic presentation 
is lymphomatous polyposis (5). The authors report a case 
of a colic MCL of the cecum in a 43-year-old male patient 
with unusual endoscopic features. 
CASE REPORT
A 43-year-old male with a previous history of dyslipidemia 
and medicated with atorvastatin was referred to our unit 
due to cramping abdominal pain with a 2-month duration. 
On physical examination, the abdomen was normal and 
no organomegaly or palpable lymph nodes were noted. 
The blood count revealed a microcytic and hypochromic 
anemia (hemoglobin 10.7 g/dl), with no other abnormalities. 
During the investigation, the patient underwent an esoph-
agogastroduodenoscopy that was normal and a colonosco-
py that demonstrated a bulky exophytic and ulcerous lesion 
with necrotic areas in the cecum. Underneath the lesion, 
there was normal ileal mucosa compatible with ileo-colic 
intussusception (Fig. 1). In addition, a subepithelial lesion 
Primary colon mantle lymphoma: 
a misleading macroscopic appearance!
Cátia Arieira1,2,3, Francisca Dias de Castro1,2,3, Pedro Boal Carvalho1,2,3 and José Cotter1,2,3
1Gastroenterology Department. Hospital da Senhora da Oliveira. Guimarães, Portugal. 2Life and Health Sciences Research Institute. School of 
Medicine. University of Minho. Braga/Guimarães, Portugal. 3ICVS/3B’s. PT Government Associate Laboratory. Braga/Guimarães, Portugal
Arieira C, Dias de Castro F, Boal Carvalho P, Cotter J. Primary colon mantle 
lymphoma: a misleading macroscopic appearance! Rev Esp Enferm Dig 2019; 
111(12):965-967
DOI: 10.17235/reed.2019.6405/2019
Received: 07/06/2019 · Accepted: 03/07/2019
Correspondence: Cátia Arieira. Hospital da Senhora da Oliveira. Rua dos Cutileiros, 114. 4835-044 Creixomil, Guim-
arães. Portugal. e-mail: catia_arieira@hotmail.com
Author´s contributions: Arieira C drafted the manuscript. Dias de Castro F and Boal 
Carvalho P revised the manuscript. Cotter J critically revised the manuscript and ap-
proved the final version for submission.
Fig. 1. Exophytic and ulcerous lesion with necrotic 
areas in the cecum.
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imab, cyclophosphamide, vincristine and prednisone) and 
R-DHAP (rituximab-dexamethasone, cisplatin and cytar-
abine) followed by autologous stem cell transplantation 
(ASCT) for consolidation was proposed. Thus far, the patient 
is well and undergoing chemotherapy.
DISCUSSION
MCL was recognized since 1994 as a non-Hodgkin B-cell 
lymphoma that originated in the mantle region of the lym-
phoid follicles, characterized by the overexpression of the 
cyclin-D1 gene as a result of the chromosomal translocation 
t(11; 14) (q13; q32) (1). On immunohistochemistry, tumor 
cells are characteristically CD5 and pan B-cell antigen pos-
itive (CD19, CD20, CD22) and negative for the expression 
of CD10 and CD23 (1).
MCL is an uncommon subtype of NHL that comprises 2-10% 
of NHBCL, usually with an aggressive behavior and a medi-
an overall survival of three to five years (6). MCL most com-
monly affects males (2:1) and usually presents in the fifth 
or sixth decade of life (1). The usual presentation is general-
ized lymphadenopathy, although extranodal involvement is 
common at sites such as the peripheral blood, bone marrow 
and gastrointestinal tract (2,6). Primary MCL of the colon is 
a rare entity and the most common symptoms are abdom-
inal pain and weight loss, with a palpable abdominal mass 
identified on physical examination (7). The most common 
sites of involvement are the ileocecal region and cecum and 
the macroscopic appearance varies from a tumoral mass, 
ulcer and mucosal thickness to multiple polypoid lesions 
(7). The most common endoscopic feature of primary intes-
tinal MCL is multiple lymphomatous polyposis, which has 
been described in some reports (1). There are few reports 
in literature of a single colonic mass as a presentation of 
primary colic MCL (8,9). 
With regard to prognosis, the median duration of remission 
in most reported trials was 1.5-3 years (1). The Mantle Cell 
Lymphoma International Prognostic Index (MIPI) score is 
frequently used to assess prognosis, which includes fac-
tors such as age, sex, performance status, LDH level, white 
blood cell count and the percentage of Ki-67-positive cells 
determined by immunohistochemistry (1). Patients are 
stratified into three risk groups: low risk (5-year overall 
survival rate of 60%), intermediate risk (median survival 
51 months) and high risk (median survival 29 months) (1). 
There is currently no standard of care for patients with new-
ly diagnosed MC due to the rarity of MCL (1). However, ther-
apy usually consists of systemic chemotherapy with CHOP 
regimen (cyclophosphamide, hydroxydaunomycin, Onco-
vin® [vincristine] and prednisone), hyper-CVAD (hyperfrac-
tionated cyclophosphamide, vincristine and doxorubicin 
[adriamycin], dexamethasone, methotrexate and cytara-
bine) with or without rituximab, R-CHOP alternating with 
R-DHAP (rituximab, cisplatin, cytarabine, dexamethasone), 
hyper-CVAD with autologous stem cell transplantation and 
single alkylating agents like chlorambucil (1). Salvage ther-
apies such as bortezomib, lenalidomide and ibrutinib have 
been used for relapsed and refractory disease. The role of 
surgery in primary gastrointestinal lymphoma is contro-
versial and is usually restricted to patients presenting with 
intestinal occlusion, bleeding and perforation, as in the case 
described here (10). 
was identified at the rectum-sigmoid transition, 18 cm from 
the anal verge that was covered by 15 mm of normal mu-
cosa (Fig. 2). The remaining colonic segments were normal.
Biopsies were taken from the mass and the subepitheli-
al lesion, which showed atypical lymphocytes infiltrating 
the lamina propria in both samples. The tumor cells were 
diffusely positive for CD5, CD20, CD43, CD79a, bcl-2 and 
cyclin D1 on immunohistochemical staining, which was 
consistent with the diagnosis of MCL. Subsequently, ab-
dominal CT scan with intravenous contrast administration 
was performed for staging. This confirmed the presence of 
a transverse colon invagination with diffuse parietal thick-
ening with multiple satellite enlarged lymph nodes asso-
ciated with fat striation, which was compatible with local 
spread (Fig. 3).
Due to his symptoms, he subsequently underwent a lapa-
roscopic right hemicolectomy and 10 cm enterectomy and 
the pathologic examination confirmed the diagnosis of lym-
phomatous polyposis MCL. In addition, a bone marrow core 
biopsy showed marrow involvement by MCL.
Combining all the findings, the patient was classified as 
stage IV-a according to the Ann Harbor classification. A 
treatment regimen of chemotherapy with R-CHOP (ritux-
Fig. 2. Subepithelial lesion of the rectum-sigmoid 
transition.
Fig. 3. Abdominal CT scan with intravenous contrast 
administration.
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In conclusion, here we describe a case of primary colonic 
MCL with an unusual presentation. Although a rare entity, 
primary colonic lymphomas should be included in the dif-
ferential diagnosis of single colonic lesions. The awareness 
of such occurrences is necessary and may help with the 
differential diagnosis of a colon single mass. 
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